This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Assistance Publique-Hopitaux De Paris, Iltoo Pharma, National Institute of Health and Medical Research. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 331 
1 out of 4 
1 out of 1,853 
Years Active: 2025
Title: Nicolas Billiald: Innovator in Immunotherapy
Introduction
Nicolas Billiald is a prominent inventor based in Paris, France. He has made significant contributions to the field of immunotherapy, particularly in the treatment of autoimmune and inflammatory disorders. His innovative approach combines interleukin-2 with an interleukin-1 inhibitor, showcasing his commitment to advancing medical science.
Latest Patents
Nicolas Billiald holds 1 patent for his invention titled "Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof." This patent relates to a combination of interleukin-2 (IL-2) and an interleukin-1 (IL-1) inhibitor, aimed at treating autoimmune and inflammatory disorders in subjects. The invention also includes a pharmaceutical composition comprising IL-2 and an IL-1 inhibitor, as well as a conjugate that features IL-2 conjugated to an IL-1 inhibitor.
Career Highlights
Throughout his career, Nicolas has worked with notable organizations such as Iltoo Pharma and Sorbonne Université. His work in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his research and development efforts.
Collaborations
Nicolas Billiald has collaborated with esteemed colleagues, including David Klatzmann and Jérémie Mariau. These partnerships have contributed to the advancement of his research and the successful development of his patented innovations.
Conclusion
Nicolas Billiald is a key figure in the field of immunotherapy, with a focus on innovative treatments for autoimmune and inflammatory disorders. His contributions through patents and collaborations highlight his dedication to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile